<--- Back to Details
First PageDocument Content
Anatomy / Biotechnology / Beta-lactam antibiotics / GlaxoSmithKline / Immunology / Biosensor / Amoxicillin / Allergy / Immunoglobulin E / Biology / Medicine / Immune system
Date: 2015-04-16 19:19:08
Anatomy
Biotechnology
Beta-lactam antibiotics
GlaxoSmithKline
Immunology
Biosensor
Amoxicillin
Allergy
Immunoglobulin E
Biology
Medicine
Immune system

Nanoplasmonic biosensor for drug allergy diagnosis

Add to Reading List

Source URL: phys.org

Download Document from Source Website

File Size: 21,50 KB

Share Document on Facebook

Similar Documents

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

DocID: 1rgTJ - View Document

SuppreMol_Crawford Release ENG_Mar 4, 2015

SuppreMol_Crawford Release ENG_Mar 4, 2015

DocID: 1qGKf - View Document

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

DocID: 1qDqa - View Document

KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche  Dr. Oliver Horlacher

KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche Dr. Oliver Horlacher

DocID: 1qxAK - View Document

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

DocID: 1qs00 - View Document